|
|
||||||||
|
|||||||||
|
|||||||||
 |
|
|
|
Drugs: Uprizing 2.0
Contact: FOR IMMEDIATE RELEASE - October 3, 2011, Marietta, Georgia. Superior Metabolic Technologies Inc of Marietta, Georgia is voluntarily recalling all lots of the testosterone booster Uprizing 2.0 because tests have shown the product appears to contain superdrol, a synthetic steroid, making it an unapproved new drug. On August 5 the FDA made Superior Metabolic Technologies Inc aware that Uprizing 2.0 contains superdrol which is banned by the FDA. This led to the recall of the product. Acute liver injury is known to be a possible harmful effect of using products containing synthetic anabolic steroids. In addition, use of synthetic anabolic steroids may cause other serious long-term adverse health consequences in men, women, and children. These include shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher prediction to misuse other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death. Uprizing 2.0 was distributed through retail health food stores in Alabama, Arizona, California, Georgia, Mississippi, New Jersey, South Carolina, and Texas. Uprizing 2.0 comes in a black plastic bottle with a black, red, and silver label and contains 90 capsules. The SMT logo is center top on the bottle. Consumers who purchased Uprizing 2.0 are urged to return it to the place of purchase for a full refund. Consumers with questions may contact the company at 1-888-445-3230, from 10 AM to 6 PM EST Monday through Friday. Adverse reactions or quality problems experienced with the use of these products may be reported to Superior Metabolic Technologies Inc toll free at 1-888-445-3230 or to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax. Online: www.fda.gov/medwatch/report.htm Regular mail: Use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm Mail to address on the pre-addressed form. Fax: 1-800-FDA-0178. This voluntary recall is being conducted with the knowledge of the U.S. Food & Drug Administration. Medical Devices: Shoulderflex
Contact: FOR IMMEDIATE RELEASE - August 31, 2011 - In cooperation with the Food and Drug Administration (FDA), King International LLC Is initiating a recall of the Shoulderflex massager due to a report of a strangulation and death. Consumers, retailers and catalog sellers are being advised to immediately stop using Shoulderflex massagers, and to safely dispose of them in the trash. 
This announcement relates to all of the approximately 12,000 Shouderflex massagers which were sold between 2003 and 2011. The devices were sold at various stores (including Relax the Back), in catalogs (including Lifestyle Fascination), and online retailers (including Amazon) in the United States. King International advises that the device components be disposed of separately so that the massager cannot be reassembled and used. The most effective way to do that is to dispose of the power supply separate from the massager unit, and to remove the massage fingers and dispose of them separately. This is a voluntary recall program conducted by King International as part of its commitment to safety. There has been a report of a strangulation and death. There was a warning never to wear a necklace to avoid entanglement. King International shares FDA’s desire to take prompt action to reduce the risk of injury. Accordingly, King International asks customers to immediately stop using Shoulderflex massagers and to safely dispose of them in the trash, and for retailers and catalog sellers to take similar action. Additional information about this recall campaign can be obtained from King International LLC at (503) 524-7046, through its website (www.shoulderflex.com) or by writing to King International at PO Box 2384, Beaverton, OR 97075. |
|
|
|